BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22348081)

  • 21. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
    Gaspar NJ; Li L; Kapoun AM; Medicherla S; Reddy M; Li G; O'Young G; Quon D; Henson M; Damm DL; Muiru GT; Murphy A; Higgins LS; Chakravarty S; Wong DH
    Mol Pharmacol; 2007 Jul; 72(1):152-61. PubMed ID: 17400764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF-dependent signaling.
    Francki A; Motamed K; McClure TD; Kaya M; Murri C; Blake DJ; Carbon JG; Sage EH
    J Cell Biochem; 2003 Mar; 88(4):802-11. PubMed ID: 12577314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SPARC mediates early extracellular matrix remodeling following myocardial infarction.
    McCurdy SM; Dai Q; Zhang J; Zamilpa R; Ramirez TA; Dayah T; Nguyen N; Jin YF; Bradshaw AD; Lindsey ML
    Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H497-505. PubMed ID: 21602472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SPARC-thrombospondin-2-double-null mice exhibit enhanced cutaneous wound healing and increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges.
    Puolakkainen PA; Bradshaw AD; Brekken RA; Reed MJ; Kyriakides T; Funk SE; Gooden MD; Vernon RB; Wight TN; Bornstein P; Sage EH
    J Histochem Cytochem; 2005 May; 53(5):571-81. PubMed ID: 15872050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of SPARC in the TRAMP model of prostate carcinogenesis and progression.
    Said N; Frierson HF; Chernauskas D; Conaway M; Motamed K; Theodorescu D
    Oncogene; 2009 Oct; 28(39):3487-98. PubMed ID: 19597474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Influence of the Extracellular Matrix in Inflammation: Findings from the SPARC-Null Mouse.
    Riley HJ; Bradshaw AD
    Anat Rec (Hoboken); 2020 Jun; 303(6):1624-1629. PubMed ID: 30980479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired wound healing in mice deficient in a matricellular protein SPARC (osteonectin, BM-40).
    Basu A; Kligman LH; Samulewicz SJ; Howe CC
    BMC Cell Biol; 2001; 2():15. PubMed ID: 11532190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges in SPARC-null mice.
    Bradshaw AD; Reed MJ; Carbon JG; Pinney E; Brekken RA; Sage EH
    Wound Repair Regen; 2001; 9(6):522-30. PubMed ID: 11896995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SPARC regulates the expression of collagen type I and transforming growth factor-beta1 in mesangial cells.
    Francki A; Bradshaw AD; Bassuk JA; Howe CC; Couser WG; Sage EH
    J Biol Chem; 1999 Nov; 274(45):32145-52. PubMed ID: 10542250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of Sparc in p53-null Astrocytes Promotes Macrophage Activation and Phagocytosis Resulting in Decreased Tumor Size and Tumor Cell Survival.
    Thomas SL; Schultz CR; Mouzon E; Golembieski WA; El Naili R; Radakrishnan A; Lemke N; Poisson LM; Gutiérrez JA; Cottingham S; Rempel SA
    Brain Pathol; 2015 Jul; 25(4):391-400. PubMed ID: 24862407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of SPARC expression in pancreatic cancer progression and patient survival.
    Gundewar C; Sasor A; Hilmersson KS; Andersson R; Ansari D
    Scand J Gastroenterol; 2015; 50(9):1170-4. PubMed ID: 25765175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of SPARC in lens epithelial cells results in altered adhesion and extracellular matrix production in vitro.
    Weaver MS; Sage EH; Yan Q
    J Cell Biochem; 2006 Feb; 97(2):423-32. PubMed ID: 16211577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells.
    Francki A; McClure TD; Brekken RA; Motamed K; Murri C; Wang T; Sage EH
    J Cell Biochem; 2004 Apr; 91(5):915-25. PubMed ID: 15034927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type I collagen-deficient Mov-13 mice do not retain SPARC in the extracellular matrix: implications for fibroblast function.
    Iruela-Arispe ML; Vernon RB; Wu H; Jaenisch R; Sage EH
    Dev Dyn; 1996 Oct; 207(2):171-83. PubMed ID: 8906420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Collagen accumulation is decreased in SPARC-null mice with bleomycin-induced pulmonary fibrosis.
    Strandjord TP; Madtes DK; Weiss DJ; Sage EH
    Am J Physiol; 1999 Sep; 277(3):L628-35. PubMed ID: 10484471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SPARC regulates collagen interaction with cardiac fibroblast cell surfaces.
    Harris BS; Zhang Y; Card L; Rivera LB; Brekken RA; Bradshaw AD
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H841-7. PubMed ID: 21666116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic stellate cells derived from human pancreatic cancer demonstrate aberrant SPARC-dependent ECM remodeling in 3D engineered fibrotic tissue of clinically relevant thickness.
    Tanaka HY; Kitahara K; Sasaki N; Nakao N; Sato K; Narita H; Shimoda H; Matsusaki M; Nishihara H; Masamune A; Kano MR
    Biomaterials; 2019 Feb; 192():355-367. PubMed ID: 30476717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions.
    Sato N; Fukushima N; Maehara N; Matsubayashi H; Koopmann J; Su GH; Hruban RH; Goggins M
    Oncogene; 2003 Aug; 22(32):5021-30. PubMed ID: 12902985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased ADAMTS1 mediates SPARC-dependent collagen deposition in the aging myocardium.
    Toba H; de Castro Brás LE; Baicu CF; Zile MR; Lindsey ML; Bradshaw AD
    Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E1027-35. PubMed ID: 27143554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength.
    Bradshaw AD; Puolakkainen P; Dasgupta J; Davidson JM; Wight TN; Helene Sage E
    J Invest Dermatol; 2003 Jun; 120(6):949-55. PubMed ID: 12787119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.